false 0001718500 0001718500 2024-04-09 2024-04-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 10, 2024

 

 

 

AXIL BRANDS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-41958   47-4125218

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

         
901 Fremont Avenue, Unit 158, Alhambra, CA   91803
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (888) 638-8883

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.0001 per share AXIL The NYSE American LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

 

 

 
 
  Item 2.02 Results of Operations and Financial Condition.

 

On April 10, 2024, Axil Brands, Inc. (the “Company”) issued a press release announcing its consolidated financial results for the three and nine months ended February 29, 2024. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

Pursuant to the rules and regulations of the Securities and Exchange Commission, such exhibit and the information set forth therein and in this Item 2.02 have been furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to liability under that section nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing regardless of any general incorporation language.

 

  Item 9.01 Financial Statements and Exhibits.

 

(d)       Exhibits

 

Exhibit No.   Description
99.1   Earnings Press Release of Axil Brands, Inc., dated April 10, 2024.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 -1-

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  AXIL BRANDS, INC.
   
Date: April 10, 2024

/s/ Jeff Toghraie

  Name: Jeff Toghraie
  Title: Chief Executive Officer

 

 -2-

 

 

AXIL Brands, Inc. Reports Third Quarter Fiscal Year 2024 Financial Results

 

LOS ANGELES, April 9, 2024 (GLOBE NEWSWIRE) – AXIL Brands, Inc. (“AXIL,” “we,” “us,” “our,” or the “Company”) (NYSE American: AXIL), an emerging global consumer products company for AXIL® hearing protection and enhancement products and Reviv3® hair and skin care products, today announced financial and operational results for the third quarter ended February 29, 2024.

 

Highlights for the Quarter Ended February 29, 2024

 

·Net Sales (revenue) increased 14.4% to approximately $6.47 million in the third quarter, as compared to the prior year period.

 

·Gross profit as a percentage of sales was 71.5% in the third quarter, as compared to 74.6% for the prior year period.

 

·Operating expenses as a percentage of net revenue were 73.1% in the third quarter, compared to 70.7% for the prior year period.

 

·Loss before provision for income taxes was $46,345 and benefit provision from income taxes was $827,436 in the third quarter.

 

·Reported third quarter net income of $781,091 or $0.04 on a fully diluted basis compared to $162,048 or $0.01 for the prior year period.

 

Key Updates Since AXIL’s Last Quarterly Earnings Release

 

·As part of our rebranding the Company changed its name to AXIL Brands, Inc. and stock ticker symbol to “AXIL”.

 

·Completed uplist to the NYSE American Stock Exchange.

 

·In March 2024, AXIL repurchased 207,748,250 shares of Series A preferred stock equivalent, in the aggregate, to 10,387,413 shares of the Company’s common stock on an as converted basis resulting in the reduction of approximately 83% of the Company’s outstanding Series A preferred shares or approximately 55% of the Company’s total outstanding shares on a fully diluted basis.

 

“We are extremely pleased with our business performance and the significant objectives achieved during this quarter. Our successful listing on the NYSE American stock exchange and recent repurchase of our Series A preferred shares enhances our ability to execute our enterprise growth strategy and unlock value for our shareholders.” Commented Jeff Toghraie, Chairman and Chief Executive Officer. “Looking ahead, we remain committed to expansion into new markets, optimizing operations and creating sustainable long term growth.”

 

 

 

Financial Tables

 

AXIL BRANDS, INC. AND SUBSIDIARY

CONSOLIDATED BALANCE SHEETS

 

   February 29, 2024  May 31, 2023
   (Unaudited)   
       
ASSETS          
 CURRENT ASSETS:          
 Cash  $4,887,567   $4,832,682 
 Accounts receivable, net   719,504    417,016 
 Inventory, net   3,443,293    1,311,864 
Due from related party   18,536    —   
 Prepaid expenses and other current assets   656,328    801,360 
 Deferred tax asset   234,161    —   
           
 Total Current Assets   9,959,389    7,362,922 
           
 OTHER ASSETS:          
 Property and equipment, net   212,146    157,463 
 Intangible assets, net   324,549    382,674 
 Right of use asset   53,224    101,845 
 Other assets   12,195    12,195 
 Goodwill   2,152,215    2,152,215 
           
 Total Other Assets   2,754,329    2,806,392 
           
 TOTAL ASSETS  $12,713,718   $10,169,314 
           
 LIABILITIES AND STOCKHOLDERS' EQUITY          
           
 CURRENT LIABILITIES:          
 Accounts payable  $1,890,844   $908,606 
 Customer deposits   37,140    183,688 
 Equipment payable, current   —      2,200 
 Contract liabilities, current   880,450    827,106 
 Notes payable, current   3,310    172,588 
 Due to related party   —      158,072 
 Lease Liability, current   54,322    65,824 
 Income Tax Liability   68,019    230,913 
 Other current liabilities   307,794    305,664 
           
 Total Current Liabilities   3,241,879    2,854,661 
           
 LONG TERM LIABILITIES:          
 Notes payable, long term   143,840    —   
 Lease liability, long term   —      36,752 
 Contract liabilities, long term   541,108    605,942 
           
 Total Long Term Liabilities   684,948    642,694 
           
 Total Liabilities   3,926,827    3,497,355 
           
 Commitments and contingencies (see Note 11)   —      —   
           
 STOCKHOLDERS' EQUITY:          
Preferred stock, $0.0001 par value; 300,000,000 shares authorized; 250,000,000 shares issued and outstanding as of February 29, 2024 and May 31, 2023, respectively   25,000    25,000 
Common stock, $0.0001 par value: 450,000,000 shares authorized; 5,878,939 and 5,863,939 shares issued, and outstanding as of February 29, 2024 and May 31, 2023, respectively   588    586 
Additional paid-in capital   10,274,677    10,113,365 
Accumulated deficit   (1,513,374)   (3,466,992)
           
 Total Stockholders' Equity   8,786,891    6,671,959 
           
 TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY  $12,713,718   $10,169,314 

 

 

 

AXIL BRANDS, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

   For the Three Months Ended  For the Nine Months Ended
   February 29,  February 28,  February 29,  February 28,
   2024  2023  2024  2023
             
 Sales, net  $6,469,343   $5,656,461   $20,997,289   $16,625,818 
                     
 Cost of sales   1,845,017    1,437,976    5,467,458    4,085,645 
         25%   26%   25%
 Gross profit   4,624,326    4,218,485    15,529,831    12,540,173 
         75%   74.0%   75%
 OPERATING EXPENSES:                    
 Sales and marketing   3,398,949    3,173,383    10,278,570    8,250,257 
 Compensation and related taxes   228,869    360,802    713,504    1,214,213 
 Professional and consulting   552,922    216,687    1,471,025    832,958 
 General and administrative   547,465    251,025    1,732,942    841,761 
                     
 Total Operating Expenses   4,728,205    4,001,897    14,196,041    11,139,189 
         71%   68%   67%
 (LOSS) INCOME FROM OPERATIONS   (103,879)   216,588    1,333,790    1,400,984 
                     
OTHER INCOME (EXPENSE):                    
 Gain on debt settlement   —      —      79,182    50,500 
 Other income   6,114    —      19,138    —   
 Interest income   52,915    6,721    129,233    13,262 
 Interest expense and other finance charges   (1,495)   (1,714)   (4,779)   (4,927)
                     
Other Income, Net   57,534    5,007    222,774    58,835 
                     
 (LOSS) INCOME BEFORE PROVISION FOR INCOME TAXES   (46,345)   221,595    1,556,564    1,459,819 
                     
 (Benefit) Provision for income taxes   (827,436)   59,547    (397,054)   395,344 
                     
 NET INCOME  $781,091   $162,048   $1,953,618   $1,064,475 
                     
NET INCOME PER COMMON SHARE:                    
 Basic  $0.13   $0.03   $0.33   $0.19 
 Diluted  $0.04   $0.01   $0.11   $0.06 
                     
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:                    
 Basic   5,863,939    5,849,501    5,863,939    5,574,312 
 Diluted   18,576,914    18,629,501    18,569,140    17,497,737 

 

 

 

AXIL BRANDS, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(UNAUDITED)

 

For the nine months ended February 29, 2024
        Common Stock   Additional       Total
    Preferred Stock   Issued/Issuable   Paid-in   Accumulated   Stockholders'
    Shares   Amount   Shares   Amount   Capital   Deficit   Equity
Balance, May 31, 2023     250,000,000     $ 25,000       5,863,939     $ 586     $ 10,113,365     $ (3,466,992 )   $ 6,671,959  
                                                         
Stock options expense     —         —         —         —         153,320       —         153,320  
                                                         
Restricted stock awards     —         —         15,000       2       7,992       —         7,994  
                                                         
Net income     —         —         —         —         —         1,953,618       1,953,618  
                                                         
Balance, February 29, 2024     250,000,000     $ 25,000       5,878,939     $ 588     $ 10,274,677     $ (1,513,374 )   $ 8,786,891  
                                                         
                                                         
For the three months ended February 29, 2024  
        Common Stock   Additional       Total
    Preferred Stock   Issued/Issuable   Paid-in   Accumulated   Stockholders'
    Shares   Amount   Shares   Amount   Capital   Deficit   Equity
Balance, November 30, 2023     250,000,000     $ 25,000       5,863,939     $ 586     $ 10,215,580     $ (2,294,465 )   $ 7,946,701  
                                                         
Stock options expense     —         —         —         —         51,105       —         51,105  
                                                         
Restricted stock awards     —         —         15,000       2       7,992       —         7,994  
                                                         
Net income     —         —         —         —         —         781,091       781,091  
                                                         
Balance, February 29, 2024     250,000,000     $ 25,000       5,878,939     $ 588     $ 10,274,677     $ (1,513,374 )   $ 8,786,891  
                                                         
                                                         
For the nine months ended February 28, 2023    
        Common Stock   Additional       Total
    Preferred Stock   Issued/Issuable   Paid-in   Accumulated   Stockholders'
    Shares   Amount   Shares   Amount   Capital   Deficit   Equity
Balance, May 31, 2022     —       $ —         2,107,385     $ 211     $ 5,476,068     $ (5,291,567 )   $ 184,712  
                                                         
Shares issued for acquisition of business     250,000,000       25,000       3,659,195       366       3,982,115       —         4,007,481  
                                                         
Stock options expense     —         —         —         —         155,067       —         155,067  
                                                         
Shares to be issued for cash     —         —         97,359       9       447,840       —         447,849  
                                                         
Net income     —         —         —         —         —         1,064,475       1,064,475  
                                                         
Balance, February 28, 2023     250,000,000     $ 25,000       5,863,939     $ 586     $ 10,061,090     $ (4,227,092 )   $ 5,859,584  
                                                         
                                                         
For the three months ended February 28, 2023    
        Common Stock   Additional       Total
    Preferred Stock   Issued/Issuable   Paid-in   Accumulated   Stockholders'
    Shares   Amount   Shares   Amount   Capital   Deficit   Equity
Balance, November 30, 2022     250,000,000     $ 25,000       5,837,899     $ 583     $ 9,910,371     $ (4,389,140 )   5,546,814  
                                                         
Stock options expense     —         —         —         —         30,922       —         30,922  
                                                         
Shares to be issued for cash     —         —         26,040       3       119,797       —         119,800  
                                                         
Net income     —         —         —         —         —         162,048       162,048  
                                                         
Balance, February 28, 2023     250,000,000     $ 25,000       5,863,939     $ 586     $ 10,061,090     $ (4,227,092 )   $ 5,859,584  

 

 

 

REVIV3 PROCARE COMPANY AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

   For the Nine Months Ended
   February 29,  February 28,
   2024  2023
       
CASH FLOWS FROM OPERATING ACTIVITIES          
Net income  $1,953,618   $1,064,475 
Adjustments to reconcile net income to net cash provided by operating activities:          
     Depreciation and amortization   83,634    66,944 
     Bad debts   143,395    13,782 
     Stock based compensation   161,314    155,067 
     Gain on settlement   (79,182)   (50,500)
     Provision (benefit) for deferred income taxes   (397,054)   —   
Change in operating assets and liabilities:          
Accounts receivable   (445,883)   (134,622)
Inventory   (2,131,429)   297,213 
Prepaid expenses and other current assets   145,032    (296,787)
Deposits   —      (3,810)
Accounts payable and accrued expenses   1,061,420    87,879 
Other current liabilities   (144,052)   860,973 
  Contract liabilities   (11,490)   259,362 
           
NET CASH PROVIDED BY OPERATING ACTIVITIES   339,323    2,319,976 
           
CASH FLOWS FROM INVESTING ACTIVITIES          
Cash acquired on business acquisition   —      1,066,414 
Purchases of property and equipment   (80,192)   (65,650)
           
NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES   (80,192)   1,000,764 
           
CASH FLOWS FROM FINANCING ACTIVITIES          
Cash raised for common stock to be issued   —      447,850 
Repayment of equipment financing   (2,200)   (2,200)
Repayment of note payable   (25,438)   (22,797)
Advances (repayments) to/from a related party   (176,608)   63,008 
           
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES   (204,246)   485,861 
           
NET INCREASE IN CASH   54,885    3,806,601 
           
CASH - Beginning of period   4,832,682    373,731 
           
CASH - End of period  $4,887,567   $4,180,332 
           
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:          
Cash paid during the period for:          
Interest  $4,681   $3,173 
Income taxes  $—     $—   
           
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:          
Stock issued for asset purchase agreement  $—     $4,007,480 
Right of use assets recognized as lease liability  $—     $131,970 
Tangible assets (excluding cash) acquired in business combination  $—     $1,740,729 
Intangible assets acquired in business combination  $—     $456,945 
Goodwill acquired in business combination  $—     $2,152,215 
Liabilities assumed in business combination  $—     $1,408,823 

 

 

 

About AXIL

 

AXIL (NYSE American) is an emerging global e-commerce consumer products company. The Company is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, under the AXIL® brand and premium hair and skincare products under its in-house Reviv3 Procare brand - selling products in the United States, Canada, the European Union and throughout Asia. To learn more, please visit the Company's website at www.reviv3.com and, for the AXIL® brand, visit www.axilbrands.com.

 

Forward-Looking Statements

 

This press release contains a number of forward-looking statements within the meaning of the federal securities laws. The use of words such as “believe,” “expect,” “continue,” “will,” “prepare,” “should,” and ”focus,” among others, generally identify forward-looking statements. These forward-looking statements are based on currently available information, and management’s beliefs, projections, and current expectations, and are subject to a number of significant risks and uncertainties, many of which are beyond management’s control and may cause the Company’s results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward- looking statements. Factors that could cause actual results to differ materially from those in the forward-looking statements include, among other things: (i) the Company’s ability to grow net sales as anticipated and perform in accordance with guidance; (ii) our ability to generate sufficient revenue to support the Company’s operations and to raise additional funds or obtain other forms of financing as needed on acceptable terms, or at all; (iii) potential difficulties or delays the Company may experience in implementing its cost savings and efficiency initiatives, including integrating the AXIL® brand; (iv) the Company’s ability to compete effectively with other hair and skincare companies and hearing enhancement and protection companies; (v) the concentration of the Company’s customers, potentially increasing the negative impact to the Company by changing purchasing or selling patterns; (vi) changes in laws or regulations in the United States and/or in other major markets, such as China, in which the Company operates, including, without limitation, with respect to taxes, tariffs, trade policies or product safety, which may increase the Company product costs and other costs of doing business, and reduce the Company’s earnings; and (vii) the impact of unstable market and general economic conditions on the Company’s business, financial condition and stock price, including inflationary cost pressures, the possibility of an economic recession and other macroeconomic factors, geopolitical events, and uncertainty, decreased discretionary consumer spending, supply chain disruptions and constraints, labor shortages, ongoing economic disruption, including the effects of the Ukraine-Russia conflict and the Israel-Hamas conflict, and other downturns in the business cycle or the economy. There can be no assurance as to any of these matters, and potential investors are urged to consider these factors carefully in evaluating the forward-looking statements. Other important factors that may cause actual results to differ materially from those expressed in the forward-looking statements are discussed in the Company’s filings with the U.S. Securities and Exchange Commission. These forward-looking statements speak only as of the date hereof. Except as required by law, the Company does not assume any obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future.

 

Investor Relations:

AXIL Investor Relations Team
(888) 638-8883
investors@axilbrands .com

 

 

v3.24.1.u1
Cover
Apr. 09, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Apr. 10, 2024
Entity File Number 001-41958
Entity Registrant Name AXIL BRANDS, INC.
Entity Central Index Key 0001718500
Entity Tax Identification Number 47-4125218
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 901 Fremont Avenue
Entity Address, Address Line Two Unit 158
Entity Address, City or Town Alhambra
Entity Address, State or Province CA
Entity Address, Postal Zip Code 91803
City Area Code (888)
Local Phone Number 638-8883
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol AXIL
Security Exchange Name NYSEAMER
Entity Emerging Growth Company false

Reviv3 Procare (QB) (USOTC:RVIV)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Reviv3 Procare (QB) Charts.
Reviv3 Procare (QB) (USOTC:RVIV)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Reviv3 Procare (QB) Charts.